“Our large-scale, international, real-world analysis supports the absence of a clinical benefit of chloroquine and hydroxychloroquine and points to potential harm in hospitalised patients with COVID-19,” the study reads.
Hydroxychloroquine has not been shown to be effective in treating COVID-19 and can cause serious side effects.
Hydroxychloroquine can prevent lupus flares and increase long-term survival of patients with the disease. Without it, however, lupus patients stand to endure more pain and suffering.
Two studies released this week found that hydroxychloroquine and chloroquine led to more fatalities among coronavirus patients.